Long-term Daily Use of Trazenta® Tablets in Patients With Type 2 Diabetes Mellitus

NCT01650259 · clinicaltrials.gov ↗

COMPLETED

Status

4876

Enrollment

INDUSTRY

Sponsor class

Conditions

Diabetes Mellitus, Type 2

Interventions

DRUG: OAD
DRUG: Trazenta

Sponsor

Boehringer Ingelheim

Collaborators

[object Object]